1 to 9 of 31 results

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted


China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

MRCF invests in Australian antibiotics start-up Auspherix


Auspherix Pty, an early stage anti-infectives company developing novel antibiotics to treat resistant…

Antibiotics and Infectious diseasesAsia-PacificAuspherixAustraliaFinancialPharmaceuticalResearch

Eisai takes over marketing authorization for Gliadel, and joins TB partnership

Eisai takes over marketing authorization for Gliadel, and joins TB partnership


Japanese drug major Eisai (TYO: 4523) will become the Marketing Authorization Holder for the antineoplastic…

Antibiotics and Infectious diseasesAsia-PacificEisaiGliadelLicensingNobelpharmaOncologyPharmaceutical

UK’s Helperby in deal with Cadila on ARB research and commercialization


Privately-held Indian drugmaker Cadila Pharmaceuticals and UK based antibiotics discovery company, Helperby…

Antibiotics and Infectious diseasesAsia-PacificCadila PharmaceuticalsHelperby TherapeuticsMarkets & MarketingPharmaceuticalResearch

Venus gets GMP certifications from Ukraine


Indian R&D-based drugmaker Venus Remedies (BSE: 526953) has been able to gain a Good Manufacturing Practice…

Antibiotics and Infectious diseasesAsia-PacificEuropeMarkets & MarketingOncologyPharmaceuticalProductionRegulationVenus Remedies

India must address worrying stock out of tuberculosis drugs, says MSF


The Indian government must urgently address the persistent issues and almost routine delays of procuring…

Antibiotics and Infectious diseasesAsia-PacificHealthcareMarkets & MarketingPharmaceuticalPolitics

Cempra out-licenses solithromycin to Toyama Chemical in Japan


USA-based clinical-stage antibiotics developer Cempra (Nasdaq: CEMP) has signed an exclusive license…

Antibiotics and Infectious diseasesAsia-PacificCempraLicensingPharmaceuticalsolithromycinToyama

BioAlliance Pharma pursues development plan for Loramyc in Japan through partner Sosei


French orphan oncology and supportive care specialist BioAlliance Pharma (Euronext Paris: BIO) says its…

Antibiotics and Infectious diseasesAsia-PacificBioAlliance PharmaLoramycOravigPharmaceuticalRegulationResearchSosei

1 to 9 of 31 results



Back to top